by Clinical Neuropsychologist Online | Thursday, February 29, 2024 | Neuroscience
Nature Neuroscience, Published online: 29 February 2024; doi:10.1038/s41593-024-01593-8Astrocytes have important roles in disease and are difficult to modulate, owing to a paucity of known targets. Clayton et al. develop a screening platform to unbiasedly identify...
by Clinical Neuropsychologist Online | Wednesday, February 28, 2024 | Dementia
Abstract INTRODUCTION Alzheimer’s disease (AD) trial participants are often screened for eligibility by brain amyloid positron emission tomography/cerebrospinal fluid (PET/CSF), which is inefficient as many are not amyloid positive. Use of blood-based biomarkers...
by Clinical Neuropsychologist Online | Tuesday, February 27, 2024 | Dementia
Abstract INTRODUCTION Alzheimer’s disease (AD) involves the complement cascade, with complement component 3 (C3) playing a key role. However, the relationship between C3 and amyloid beta (Aβ) in blood is limited. METHODS Plasma C3 and Aβ oligomerization tendency...
by Clinical Neuropsychologist Online | Monday, February 26, 2024 | Dementia
Dementia, Volume 23, Issue 4, Page 584-609, May 2024. Participating in physical activity is beneficial for older people with dementia. Little is known however about the perceptions of people living with dementia undertaking an online-delivered exercise program. This...
by Clinical Neuropsychologist Online | Monday, February 26, 2024 | Paediatric Neuropsychology
Volume 30, Issue 8, November 2024, Page 1215-1233. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Mia A. McLean Joanne Weinberg Anne R. Synnes Steven P....
